Communications Equipment

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D. Ontrak, Inc. (NASDAQ: OTRK) shares rose 64.6% to $1.12 in pre-market trading. Ontrak recently reported closing of registered direct...

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556. ChemoCentryx, Inc. (NASDAQ: CCXI) gained 110% to $50.68 after the company, and Amgen, announced an agreement...

Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 in pre-market trading after jumping over 25% on Wednesday. Samsung Biologics and the company...

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022. SKYX Platforms Corp. (NASDAQ: SKYX) gained 68.6% to settle at $7.03. Benchmark initiated...

  Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023. Addex Therapeutics Ltd (NASDAQ: ADXN) gained 110....

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 22.1% to $0.2050 in pre-market trading. Allena Pharmaceuticals disclosed a new meeting date and new record date for special meeting to approve reverse stock split. Aditxt, Inc. (NASDAQ: ADTX) rose 20.9% to $0.2085 in pre-market trading after...

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share. Canoo Inc. (NASDAQ: GOEV) shares climbed 53.2% to close at $3.63 after Walmart signed a definitive...

Gainers Canoo Inc. (NASDAQ: GOEV) shares jumped 79.9% to $4.2627 after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Lifestyle Delivery Vehicle, with the option to purchase up to 10,000 units. Histogen Inc. (NASDAQ: HSTO...

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. Pliant Therapeutics, Inc. (NASDAQ: PLRX) shares surged 159% to close at $23.00 on Monday after the company said its treatment for Idiopathic...

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. La Jolla Pharmaceutical Company (NASDAQ: LJPC) gained 80.9% to $6.13 after Innoviva entered into a definitive...

Gainers Inpixon (NASDAQ: INPX) rose 25.8% to $0.2305 in pre-market trading after gaining more than 22% on Friday. Nyxoah S.A. (NASDAQ: NYXH) rose 25.3% to $10.02 in pre-market trading after the company received FDA IDE approval to initiate the ACCCESS study of Genio in complete concentric collapse...

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market. Grove Collaborative Holdings, Inc. (NYSE: GROV) shares climbed 84.3% to close at $7.37 amid news the company...

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. Ensysce Biosciences...

  Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. NeuroSense Therapeutics Ltd. (...

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 149.3% to $1.56 in pre-market trading after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. 374Water, Inc. (...